AngioDynamics, Inc. (ANGO) financial statements (2020 and earlier)

Company profile

Business Address 14 PLAZA DRIVE
LATHAM, NY 12110
State of Incorp. DE
Fiscal Year End May 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

11/30/2019
TTM
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments412287549342018
Cash and cash equivalents412287448321816
Short-term investments  11222
Receivables34443945535862
Inventory, net of allowances, customer advances and progress billings50404955556761
Inventory50404955556761
Prepaid expense 233323
Other undisclosed current assets6223188
Total current assets:132315168154146156152
Noncurrent Assets
Property, plant and equipment28244245485567
Intangible assets, net (including goodwill)556493492507528543566
Goodwill360348361361361361360
Intangible assets, net (excluding goodwill)196145130146167182205
Other noncurrent assets9432555
Other undisclosed noncurrent assets     1510
Total noncurrent assets:593521537554581618648
TOTAL ASSETS:725836705708727774800
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46615057385359
Accounts payable18231618162433
Accrued liabilities28383439221817
Employee-related liabilities     108
Taxes payable    001
Debt 8551695
Restructuring reserve     01
Business combination, contingent consideration, liability15210131016
Deferred revenue and credits   10
Other liabilities10     1
Other undisclosed current liabilities     (11)(9)
Total current liabilities:57735772676172
Noncurrent Liabilities
Long-term debt and lease obligation 1248791105129138
Long-term debt, excluding current maturities 1248791105129138
Liabilities, other than long-term debt29924263751
Other liabilities31111 0
Business combination, contingent consideration, liability26913253751
Other undisclosed noncurrent liabilities251517262211
Total noncurrent liabilities:54148106121153167190
Total liabilities:111222163193220229262
Stockholders' equity
Stockholders' equity attributable to parent614615543515507545538
Common stock0000000
Treasury stock, value(6)(6)(6)(6)(2)(2)(2)
Additional paid in capital558555544533526520508
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(2)(1)
Retained earnings (accumulated deficit)62665(11)(16)2833
Total stockholders' equity:614615543515507545538
TOTAL LIABILITIES AND EQUITY:725836705708727774800

Income statement (P&L) ($ in millions)

11/30/2019
TTM
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
Revenues230271344350354357354
Revenue, net 350354357354
Cost of revenue
(Cost of Goods and Services Sold)
(88)(115)(167)(173)(180)(180)(175)
Gross profit:142156177176174177180
Operating expenses(160)(165)(166)(163)(173)(178)(166)
Operating income (loss):(18)(9)11131(1)13
Nonoperating expense(4)(5)(3)(6)(4)(7)(7)
Foreign currency transaction loss, before tax   (3)   
Other nonoperating expense(0)(5)(3)(3)(4)(7)(7)
Interest and debt expense(3)(5)(3)(3)(3)(3)(4)
Other undisclosed income from continuing operations before equity method investments, income taxes3536334
Income (loss) from continuing operations before income taxes:(22)(15)710(3)(8)6
Income tax expense (benefit)549(5)(40)5(3)
Net income (loss):(17)(11)165(44)(3)3
Other undisclosed net income attributable to parent7272     
Net income (loss) available to common stockholders, diluted:5661165(44)(3)3

Comprehensive Income ($ in millions)

11/30/2019
TTM
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
Net income (loss):(17)(11)165(44)(3)3
Other comprehensive income (loss)0(0)0(1)0(0)0
Comprehensive income (loss):(17)(12)174(44)(4)3
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)      
Comprehensive income (loss), net of tax, attributable to parent:(17)(12)174(44)(4)3

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: